The long term objective of this program is to elucidate the pathogenesis of hepatocehular carcinoma in hepatitis B virus (HBV) infection. In order to create the opportunity and the reagents to pursue these questions, we have introduced subgenolic fragments or the complete HBV genome into the germline of transgenic mice. In the course of these studies we developid a model of hepatocellular carcinoma in those lineages of transgenic mice that overexpress the HBV large envelope (preS1) polypeptide in their hepatocytes. These mice produce long subviral envelope filamentous particles which accumulate within the endoplasmic reticulum, leading to the formation of ground glass hepatocytes identical to those found in chronic HBV infection in man. For unknown reasons, these ground glass cells die and, thereby, elicit hepatocellular regeneration and a secondary inflammatory response with the eventual development of HCC. We now wish to characterize this model further, with the following Specific Aims: Speciric Aim 1. To clarify the relationship between the ground glass hepatocyte, liver cell injury and hepatocellular carcinoma in this model. Speciric Aim 2. To examine the role of oxidative damage in hepatocarcinogenesis, and the ability of antioxidants to prevent hepatocellular carcinoma in this model.
Specific Aim 3. To identify cellular genes whose expression is specifically altered during evolution of HCC that might be used to construct a tumor speciric vaccine in this model.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA054560-01
Application #
3199130
Study Section
Special Emphasis Panel (SRC (40))
Project Start
1991-07-01
Project End
1992-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Wieland, Stefan F (2015) The chimpanzee model for hepatitis B virus infection. Cold Spring Harb Perspect Med 5:
Chisari, F V; Isogawa, M; Wieland, S F (2010) Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 58:258-66
Guidotti, Luca G; Chisari, Francis V (2006) Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1:23-61
Schirmbeck, R; Zheng, X; Roggendorf, M et al. (2001) Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen. J Immunol 166:1405-13
Schirmbeck, R; Wild, J; Stober, D et al. (2000) Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen. J Immunol 164:4235-43
Chisari, F V (2000) Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol 156:1117-32
Cerny, A; Chisari, F V (1999) Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30:595-601
Chisari, F V (1997) Cytotoxic T cells and viral hepatitis. J Clin Invest 99:1472-7
Chisari, F V (1996) Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol 206:149-73
Chemin, I; Takahashi, S; Belloc, C et al. (1996) Differential induction of carcinogen metabolizing enzymes in a transgenic mouse model of fulminant hepatitis. Hepatology 24:649-56

Showing the most recent 10 out of 21 publications